1.0: INTRODUCTORY PERSPECTIVE
1.1: BACKGROUND OF THE STUDY
1.2: STATEMENT OF RESEARCH PROBLEM
1.3: AIMS AND OBJECTIVES
1.4: JUSTIFICATION OF THE STUDY
1.5: SCOPE OF THE STUDY
1.6: METHODOLOGY OF RESEARCH
1.7: LITERATURE REVIEW
1.8: ORGANIZATIONAL
LAYOUT
CHAPTER
TWO
2.0: MEANING AND
NATURE OF CONSENT
2.1: MEANING OF
CONSENT
2.2: NATURE OF
CONSENT
2.3: TYPES OF
CONSENT
2.3.1: INFORMED
CONSENT
2.3.2: EXPRESS
CONSENT
2.3.3: IMPLIED
CONSENT
2.3.4: CONSENT BY MINORS
2.3.5: PROXY OR
SURROGATE
CHAPTER
THREE
3.0: DOCTOR’S
DUTY OF DISCLOSURE IN CONSENT CASES
3.1: RISKS
3.2:
ALTERNATIVES
3.3: SIDE
EFFECTS AND CONSEQUENCES OF TREATMENT UNDERTAKEN
3.4: BENEFITS OF
TREATMENT UNDERTAKEN
CHAPTER
FOUR
4.0: CONSENT
UNDER THE NATIONAL HEALTH ACT, 2014.
4.1: HEALTH
STATUS OF THE PATIENT
4.2: DIAGNOSTIC
PROCEDURES
4.3: BENEFITS,
RISKS AND CONSEQUENCES OF THE TREATMENT UNDERTAKEN
4.4: IMPLICATION
OF REFUSING TREATMENT
4.5: VIOLATION
OF A PATIENT’S RIGHT TO CONSENT UNDER THE NATIONAL HEALTH ACT, 2014
CHAPTER
FIVE
5.0: CONCLUSION
5.1: FINDINGS
5.2: CONCLUSION
5.3:
RECOMMENDATIONS
